Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
This larger supply reduces the need for reordering and supports multi-phase research protocols
Clinical trial data reveals improvements in insulin sensitivity and glucose metabolism in obese patients treated with tesofensine, with reductions in blood sugar levels observed across all dosage groups
Using a sensitive analytical technique called mass spectrometry, they tracked the peptide as it was broken down by enzymes naturally present in the blood, and identified all the fragments that were produced
How we reviewed this article: Current Version October 03, 2025 Written By John DiBella Fact-checked By Dr
Melanotan-II is not an FDA-approved drug and is supplied for research use only
US$ 23.62
US$ 22.28
US$ 22.72
US$ 29.65
US$ 21.34
US$ 27.43
US$ 22.14
US$ 24.56
US$ 27.39
